Theseus Pharmaceuticals Inc (THRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,146 | -10,497 | -27,308 | -18,652 | -11,280 |
| Depreciation Amortization | -43 | 3 | 2 | 1 | 1 |
| Accounts payable and accrued liabilities | 504 | 423 | -150 | 837 | 247 |
| Other Working Capital | 2,031 | 928 | -4,248 | -1,405 | -2,163 |
| Other Operating Activity | 3,872 | 1,459 | 4,511 | 1,940 | 1,237 |
| Operating Cash Flow | $-15,782 | $-7,684 | $-27,193 | $-17,279 | $-11,958 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -93,477 | -90,670 | N/A | N/A | N/A |
| PPE Investments | -381 | -27 | N/A | N/A | N/A |
| Investing Cash Flow | $-93,858 | $-90,697 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 70 | N/A | 167,637 | 1,395 | 1,395 |
| Other Financing Activity | 0 | 0 | 96,140 | 98,209 | 99,692 |
| Financing Cash Flow | $70 | $N/A | $263,777 | $99,604 | $101,087 |
| Beginning Cash Position | 245,040 | 245,041 | 8,457 | 8,457 | 8,457 |
| End Cash Position | 135,470 | 146,660 | 245,041 | 90,782 | 97,586 |
| Net Cash Flow | $-109,570 | $-98,381 | $236,584 | $82,325 | $89,129 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,782 | -7,684 | -27,193 | -17,279 | -11,958 |
| Capital Expenditure | -381 | -27 | N/A | N/A | N/A |
| Free Cash Flow | -16,163 | -7,711 | -27,193 | -17,279 | -11,958 |